GAVISCONELL Liquid Mint susp en bouteille 300 ml
7680669970024
CH-66997
A02AX
04.01.0.
1 / 3
google
Details
- Product number
- 6699701
- CPT
- -
- Packaging group
- 300
- Unit
- ml
- Composition
- natrii alginas 500 mg, natrii hydrogenocarbonas 267 mg, calcii carbonas 160 mg, carbomerum 974P, natrii hydroxidum ad pH, aqua purificata, menthae piperitae aetheroleum, saccharinum natricum, propylis parahydroxybenzoas 6 mg, E 218 40 mg, ad suspensionem pro 10 ml corresp. natrium 142.6 mg.
Articles (1)
Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen
Suspension zum Einnehmen in Flaschen
300
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
267.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.0 MG | Substance | HBESI |
|
(N/A)
|
40.0 MG | Substance | HBESI |
|
(N/A)
|
142.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 10.75
Specialties list
Yes
Generic
No
SL addition date:
01/10/2020
Authorization holder
Reckitt Benckiser (Switzerland) AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 66997
- Drug name
- Gavisconell Liquid Mint, Suspension zum Einnehmen in Flaschen
- Galenic form
- SUOR
- ATC Code
- A02AX
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 01/11/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 04.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GAVISCONELL Liquid Mint susp en bouteille 300 ml
- Description (DE)
- GAVISCONELL Liquid Mint Susp in Flasche 300 ml
- Market launch
- 01/11/2018
- Narcotic (BTM)
- No